Improved inhibitory and ADMET properties of blebbistatin derivatives indicate that blebbistatin scaffold is ideal for drug development targeting myosin-2
暂无分享,去创建一个
Z. Borhegyi | Anna Á. Rauscher | A. Málnási-Csizmadia | M. Kovács | M. Gyimesi | Suman Nag | S. K. Suthar | M. Déri | P. Szabó | J. Krans | I. Lőrincz | K. Hamow | Adam Kiss | I. Tomasic | L. Kornya | J. Patrick | Kinga | Oravecz | Katalin | Monostory | Tierney | Zsolt Borhegyi